Access to Medicines - Our Approach | Takeda Pharmaceuticals
Access to Medicines
Globally, more than 2 billion people lack access to essential medicines, most of whom live in low- and middle-income countries (LMICs) and countries with evolving healthcare systems.
As an innovative biopharmaceutical company, we focus on developing life transforming medicines and vaccines that are valued by patients and society. But these only create value when the people who need them can access them – regardless of where they live or their socio-economic status. Our Access to Medicines approach is designed to expand sustainable, equitable access, especially in low- and middle-income countries (LMICs) and regions with evolving health care systems.
The three pillars of our approach
Availability
Working with stakeholders across health care ecosystems to ensure that vital medicines and vaccines are available when and where they’re needed the most. This includes accelerating registration, enabling timely market entry and ensuring reliable supply.
Accessibility
Addressing financial and systemic barriers that prevent patients from receiving treatment – through tiered and value based pricing, patient assistance programs and partnerships that address barriers to access across the patient journey.
Sustainability
Embedding access in our business model and partnering to drive long-term growth, strengthen health systems and deliver shared value for patients, societies and our business.
